Edit
CorrectSequence Therapeutics
https://www.correctsequence.com/indexLast activity: 08.09.2026
Active
CorrectSequence Therapeutics is a company that uses innovative base editing technology to help people with severe diseases. The company’s website, https://www.correctsequence.com/, provides information about their products and services.
Location: China
Employees: 1-10
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | LAV | lavfund.co... |
| - | New Allian... | nac-capita... |
Mentions in press and media 9
| Date | Title | Description |
| 08.09.2026 | Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds | Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia. SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- On September ... |
| 02.06.2026 | High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease | CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base ... |
| 06.11.2025 | The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia | CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence The... |
| 15.08.2024 | Deals in brief: Investible backs DeCarice’s hydrogen push, Komerce merges with RajaOngkir, Australia announces first round of IGP grants, and more | Investible fuels DeCarice’s hydrogen push with financial backing Venture capital firm Investible has thrown its weight behind DeCarice, an Australian startup that’s rewriting the rules for heavy-duty engines. Investible’s Climate Tech Fund,... |
| 07.08.2024 | A New Dawn in Gene Therapy: CorrectSequence Therapeutics Breaks Ground in China | In a world where medical advancements often feel like distant dreams, a recent breakthrough in gene therapy shines like a beacon of hope. CorrectSequence Therapeutics Co., Ltd. (Correctseq) has achieved a remarkable milestone by successfull... |
| 06.08.2024 | OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics | SHANGHAI, Aug. 6, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering ... |
| 05.08.2024 | OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics | SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering ... |
| 08.01.2024 | The World's First Clinical Base Editing Therapy for Hemoglobinopathy | CorrectSequence Therapeutics' CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia SHANGHAI, Jan. 8, 2024 /PRNewswire/ -- On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using... |
| - | Positive Sequence Biology | “Website description, general display the description text in the search results in the search engine, for the introduction website, suction browser click.” |